MicroRNAs (miRNAs) are small RNA molecules that regulate posttranscriptional gene expression. Previous research has suggested that aberrant miRNA expression often plays a critical role in many types of cancer, including lung cancer. However, the exact miRNAs that are involved in pulmonary carcinogenesis remain unclear. We investigated the miRNA-based molecular changes that occur in urethane-induced carcinogenicity and identified specific miRNA deregulation in pulmonary carcinogenesis induced by urethane. In this study, we used a lung cancer model in which Balb/c mice were exposed to urethane via ip injection once a week for four consecutive weeks. The mice were then killed in weeks 6, 12, or 24. Two small RNA libraries were constructed with the total RNA from the lung tumor and normal adjacent lung tissues of the urethane-injected mice collected in week 24. Using Solexa sequencing, we identified a plethora of differentially expressed miRNAs and predicted nine novel miRNAs. Further analysis demonstrated the sustainable downregulation of miR-1a in the lung tissues in lung carcinogenesis induced by urethane. The levels of miR-1a were also reduced in the serum. Our findings indicate that urethane exposure alters the expression of a cluster of miRNAs. The simultaneous downregulation of miR-1a in lung tissues and serum in urethane-induced pulmonary carcinogenesis suggests that miR-1a is associated with tumorigenesis.
Animal model systems have allowed significant advances to be made in our understanding of carcinogenicity in the field of toxicology. Urethane is a chemical carcinogen that specifically promotes the development of lung tumors (Mason et al., 2000) . In vivo, urethane is transformed into the intermediate product vinyl carbamate epoxide (VCO) in a reaction mediated by CYP2E1, a cytochrome P450 enzyme enriched in the bronchiolar Clara cells of the mouse lung. VCO then binds to DNA, causing DNA adducts to form, which are associated with genetic changes involved in the development of lung tumors (Forkert, 2010) . However, the details of the molecular changes involved in urethane-induced lung carcinogenesis have not yet been clarified. In recent years, epigenetics has attracted much attention in the study of chemical carcinogenesis, particularly CpG island methylation, histone modification, and microRNA (miRNA) activities (Bollati and Baccarelli, 2010; Lema and Cunningham, 2010) .
miRNA genes are transcribed to generate long primary miRNAs, which are processed by the RNase-III-type enzyme Drosha into precursor miRNAs in the nucleus. Each precursor miRNA is then exported to the cytoplasm by exportin 5, where it is processed by Dicer1 to generate an miRNA duplex consisting of a mature miRNA strand and a passenger miRNA strand. The mature miRNA strands are transformed into mature miRNAs (Wienholds and Plasterk, 2005) . Many passenger strands degrade quickly, although some are maintained and are functional (Mah et al., 2010; Okamura et al., 2008) . miRNAs are small noncoding RNAs that negatively regulate target genes by interacting with the 3′-untranslated regions (UTRs) of mRNAs. This interaction results in translational repression or the degradation of the mRNA (Brown and Naldini, 2009) . A single miRNA can target multiple mRNAs and approximately 30% of all protein-coding genes in humans are regulated by miRNAs (Filipowicz et al., 2008) . Accumulating evidence suggests that miRNAs are involved in a wide variety of biological processes, including cell proliferation (Brennecke et al., 2003; Cheng et al., 2005) , cell differentiation (Chen et al., 2004; Kwon et al., 2005) , and apoptosis (Cimmino et al., 2005; Xu et al., 2003) . Moreover, a number of studies have reported that miRNA expression is dysregulated in the pathogenesis of cancer, where miRNAs act as either oncogenes or tumor suppressors (Croce, 2009; Kasinski and Slack, 2011; Zhang et al., 2007) . Our previous studies also suggested that miR-106a (Jiang et al., 2011) and miR-494 (Liu et al., 2010) Recent studies have also shown that circulating miRNA can be stable in serum and can be used as an indicator of the response to xenobiotic chemicals (Laterza et al., 2009) . Many significantly altered miRNAs have been identified using miRNA detection and profiling, including miRNA microarray and high-throughput Solexa sequencing technologies. Solexa sequencing is a powerful technique for identifying and quantifying miRNAs (Morin et al., 2008) . Compared with miRNA microarray technology, this method not only identifies the expression profiles of known miRNAs but can also be used to discover novel miRNAs (Weng et al., 2010) .
Previous studies have suggested that the abnormal expression of miRNAs plays a vital role in the progression of tumorigenesis in a variety of animal models established with chemical carcinogens (Chen, 2010) . However, the mechanisms underlying the changes in miRNA expression during the development of the pulmonary carcinogenesis induced by urethane remain unclear. In this study, we investigated the changes in lung tissue miRNA expression following exposure to urethane. Using Solexa sequencing, we compared the expression profiles of known miRNAs between lung tumors and normal adjacent lung tissues from tumor-bearing mice. Several novel miRNAs were also predicted in two RNA libraries. Most importantly, our results indicate that miR-1a is significantly reduced in the lung tissues of urethane-treated mice, accompanied by its parallel reduction in the sera of mice exposed to urethane. Our results demonstrate that the carcinogen urethane disturbs miRNA expression profiles in lung tumors. The changes in miR-1a in the lung tissues and serum indicate that miR-1a is associated with the lung carcinogenesis induced by urethane.
MATeRIAlS ANd MeTHOdS
Animal treatment. Balb/c mice (8-9 weeks of age), weighing 18-20 g, were obtained from the Medical Animal Experimental Center in Guangdong, China. They were maintained under a 12-h light/dark cycle and fed a standard chow diet. The animals were allowed to acclimate for 10-14 days before the bioassay. The temperature, humidity, and ventilation in the animal room were controlled in accordance with specific-pathogen-free-grade standards. The mice were then randomly assigned to either the control (n = 30) or treatment group (n = 30). The mice in the treatment group received weekly ip injections of 1 g/kg urethane (Sigma Chemical Company, St Louis, MO) for four consecutive weeks. The mice in the control group were injected similarly with saline. Subsets of mice (at each time point: control group, n = 10; treatment group, n = 10) were killed at weeks 6, 12, and 24 after the first urethane treatment. All animal treatments were performed in accordance with a protocol approved by the Animal Care and Use Committee of Guangzhou Medical University.
Sample collection and pathological examination. Approximately 1 ml of mouse blood was collected with a syringe via the abdominal vein following ether anesthesia, and the samples were transferred to EDTA-containing tubes. The whole blood was allowed to stand for approximately 60 min at room temperature and was then centrifuged at 1200 × g for 10 min at 4°C. The supernatant was removed and subjected to high-speed centrifugation at 12,000 × g for 10 min to completely remove any cell debris. The resulting serum was divided into aliquots in 1.5-ml microcentrifuge tubes and stored at −80°C until analysis. After the mice were killed, the tumors and normal-appearing lung parenchyma tissues were dissected and examined under a dissecting microscope. One portion of normal-appearing lung parenchyma tissue and one of tumor tissue were placed in 300-700 μl of RNAlater solution (Ambion, Austin, TX) at 4°C and stored at −80°C until RNA isolation. Another portion of each tissue was fixed in buffered 4% (vol/vol) formalin for pathological examination.
RNA extraction. The total RNA containing miRNAs was isolated with TRIzol Reagent (Invitrogen) from approximately 50-100 mg of lung tissue taken from individual mice, as described by the manufacturer. The RNA quality and quantity were evaluated with a NanoDrop 1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE). The individual aliquots of RNA samples from the urethane-treated group or control group were pooled for Solexa sequencing. The remaining individual samples were used for quantitative real-time PCR (qRT-PCR).
RNA was extracted from the mouse sera using the miRNeasy Mini Kit (Qiagen, Hilden, Germany). In brief, 100 μl of serum from each animal was mixed with 500 μl of QIAzol lysis reagent (Qiagen) in a 1.5-ml Eppendorf tube. The samples were vortexed and allowed to stand for 5 min at room temperature; 200 μl of chloroform was then added to remove the protein and the samples were centrifuged. The upper aqueous layer was transferred to a new Eppendorf tube and a 1.5-fold volume of 100% ethanol was added to it and mixed thoroughly. The aqueous phase was then loaded onto an miRNeasy column (Qiagen). After the mixture had passed completely through the column, the column was washed consecutively with Buffer RWT (Qiagen) and Buffer RPE (Qiagen). The column was centrifuged at 13,000 × g and the sample eluted with 100 μl of Elution Solution (Qiagen), according to the manufacturer's protocol.
Solexa sequencing. First, we generated two RNA pools from the tissues of mice treated with urethane. The RNA pools consisted of equal amounts of total RNA from the lung tumors and from matched, normal lung tissues adjacent to the tumors. The total RNAs were used for Solexa sequencing. In brief, total RNA was purified by electrophoretic separation with 15% TBE-urea denaturing polyacrylamide gel electrophoresis and small RNA regions corresponding to the 15-35 nucleotide band in the marker lane were excised and recovered. After 5′-adapter and 3′-adapter were ligated to the small RNAs, the small RNA-adapter molecules were reverse transcribed and used as the templates for PCR amplification. Finally, two miRNA libraries were constructed and sequenced with the Illumina Genome Analyzer at Beijing Genomics Institute (Shenzhen, Guangdong, China).
qRT-PCR.
We used the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) for cDNA synthesis. We scaled down the reverse transcription reaction volume (7.5 μl) as follows: 2.5 μl of RNA extract with 20 ng of total RNA, 0.075 μl of 100mM dNTPs, 0.5 μl of MultiScribe Reverse Transcriptase (50 U/μl), 0.75 μl of 10× reverse transcription buffer, 0.095 μl of RNase inhibitor (20 U/μl), 0.5 μl of miRNA-specific stem-loop primer, and 2.08 μl of nuclease-free water. The reaction mixtures were incubated at 16°C for 30 min, at 42°C for 30 min, and at 85°C for 5 min and then stored at 4°C. Each amplification reaction was performed in a final volume of 10 μl containing 0.665 μl of cDNA, 5 μl of TaqMan Universal PCR Master Mix (Applied Biosystems), 0.5 μl of miRNA-specific probe, and 3.835 μl of nuclease-free water. Quantitative PCR was performed with the Applied Biosystems 7500 Real-Time PCR system as follows: 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Each sample was analyzed in triplicate. Because there is no current consensus on the use of an internal control for the real-time PCR analysis of serum miRNA, the relative expression levels of the miRNAs were calculated using the comparative CT method (2 −ΔΔCT ) (Schmittgen and Livak, 2008 ) with miR-16 as the endogenous control against which we normalized the data, based on other published results (Ng et al., 2009) and as recommended by the manufacturer (Applied Biosystems). An internal control U6 snRNA was also used for the normalization of tissue miRNA levels.
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Statistical analysis. Statistical analysis was performed with the SPSS 17.0 software (SPSS Inc., Chicago, IL). The unpaired Student's t-test, paired Student's t-test, one-way ANOVA, and the Mann-Whitney test were used to evaluate the differences between groups. p < 0.05 was considered to indicate a statistically significant result.
ReSUlTS

Establishment of a Mouse Model of Pulmonary Carcinogenesis
To investigate the miRNA-based molecular changes involved in chemical carcinogenesis, we constructed a Balb/c mouse model of lung cancer induced with urethane, a specific lung carcinogen. As shown in Figure 1A , there were no tumors in the lung tissues of the saline-injected mice after 6, 12, and 24 weeks. No visible tumors were observed in the mouse lung tissues 6 weeks after urethane treatment, but urethane-induced tumors appeared in the lung tissues at weeks 12 and 24 following the first administration of urethane (Fig. 1B) . At 12 weeks, there was a total of 29 lung tumors in nine mice following urethane treatment and the incidence of lung tumor was 90% in the urethane treatment group at week 12. There were 60 lung tumors in 10 mice in the urethane treatment group at week 24, with a tumor incidence of 100%. No pathological changes were observed in the normal lung tissues of the saline-injected mice at any of the three time points (Fig. 1C) . In week 6, there were no marked pathological changes in the lungs of the urethanetreated mice, apart from slight inflammatory cell infiltration, whereas lung tumors, diagnosed as adenocarcinoma by pathological analysis, were present at both week 12 and week 24 (Fig. 1D ).
Solexa Sequencing of Noncoding RNA in Lung Tissues
Two libraries of small RNAs were constructed from lung tumors and normal adjacent lung tissues collected from the urethane-treated group at week 24. Deep sequencing yielded a total of 12,495,829 and 13,903,875 raw sequence reads in the lung tumors and normal adjacent lung tissues, respectively. The low-quality tags were filtered out, the adaptor sequence at the 3′-termini was trimmed, and the 5′-adaptor contaminants formed by ligation were removed. The remaining clean reads from the lung tumors and normal adjacent lung tissues were genome annotated. The numbers and proportions of the different categories of small RNAs are shown in Supplementary table S1 and Figures 2A and 2B . The size distribution of the reads indicated that the majority of small RNAs were 22 nt in size in both the cancerous and adjacent noncancerous lung tissues (Fig. 2C) , which is within the typical size range for Dicer digestion products. This result indicates that the two small RNA libraries were highly enriched in miRNA sequences. The remaining sequences were found to be other, less abundant categories of RNAs, including noncoding RNAs (tRNA, rRNA, snRNA, snoRNA, etc.) and unannotated RNAs. We used the unannotated sequence reads in the two libraries to predict novel miRNAs using Mireap (http://sourceforge.net/projects/ mireap/). In this way, we identified 39 putative novel miRNAs in the two libraries: 22 novel miRNAs in the lung tumor library and 17 in the normal adjacent lung tissue library. Nine novel miRNAs were shared by both libraries (Supplementary table  S2 ). The number of reads for most of the novel miRNAs was much lower than those for the known miRNAs, indicating that they were usually expressed at lower levels.
Global miRNA Profiling in Pulmonary Carcinoma Induced by Urethane
Expression profiling based on Solexa sequencing was performed to identify the differential expression patterns of miRNAs in cancerous and adjacent noncancerous lung tissues. A total of 779 miRNAs (referenced to miRBase Release 14) were scanned with Solexa sequencing. We identified 612 miRNAs, comprising 436 mature miRNAs and 176 star-form FIg. 1. Gross examination and hematoxylin and eosin (H&E) staining of lung tissues and lung tumors at weeks 6, 12, and 24 after the administration of saline or urethane. Representative photographs of lungs at 6, 12, and 24 weeks after saline (A) or urethane (B) treatment. Representative pathological images of lung tissues from saline-injected mice (C) and the lung tissues and tumors from urethane-injected mice (D) at weeks 6, 12, and 24. No tumors appeared in the lungs of the saline-injected mice at the three time points. No pathological changes were observed in the lung tissues of the saline-treated control group. Lung tissues only exhibited slight inflammatory cell infiltration and the pulmonary organizational structure appeared to be normal 6 weeks after the administration of urethane. Adenocarcinomas were observed in the lungs of the urethane-injected mice at weeks 12 and 24. Arrows (B) indicate representative lung tumors. H&E results suggest that the pathological type of the tumor was adenocarcinoma (original magnification ×100).
miRNAs, in the normal adjacent lung tissue library; and 586 miRNAs, comprising 421 mature miRNAs and 165 starform miRNAs, in the lung tumor library (Supplementary tables S3 and S4). Thus, there were fewer star-form miRNAs than known mature miRNAs, although a few copies included in the star-form miRNAs may be associated with rapid degradation. The scatter plot shown in Figure 3 indicates that many miRNAs exhibited significantly different expression in the cancerous and adjacent noncancerous lung tissues. Differentially expressed miRNAs were selected for further analysis based on more restrictive criteria, as follows: (1) more than 50 copies in the lung tumor and normal adjacent tissues in the urethanetreated group, (2) a fourfold difference in expression in the lung tumor relative to its expression in the matched normal adjacent tissue in the urethane-treated group, (3) with a p value of less than 0.05, and (4) homologous mature miRNA sequences in human and mouse species. According to these principles, we identified 23 aberrantly expressed miRNAs (Table 1) , 8 of which were upregulated and 15 downregulated in the tumor tissues. These data suggest the global perturbation of miRNA expression patterns in urethane-induced pulmonary carcinogenesis.
Confirmation of Differentially Expressed miRNA by qRT-PCR
To further validate the results of Solexa sequencing, we determined the expression of five miRNAs using TaqMan qRT-PCR (miR-127, miR-433, miR-1a, miR-34c, and miR-193), selected based on the Solexa sequencing results, in 10 paired lung tumor tissues from the urethane-treated mice collected at week 24. U6 snRNA was usually used as the normalization factor in quantifying the miRNA expression in the tissues, as described previously (Melkamu et al., 2010; Yoshioka et al., 2011) . The cycle threshold (CT) values for U6 snRNA did not differ significantly in the lung tissues of the control and urethane-treated groups (Supplementary fig.  S1A ). However, qRT-PCR indicated that miR-127 (Figs. 4A and 4B) and miR-433 (Figs. 4C and 4D) were significantly upregulated in the lung tumor tissues of the urethane-treated group compared with their levels in the paired normal lung tissues (n = 10), whereas miR-1a (Figs. 4E and 4F ) and miR34c (Figs. 4G and 4H) were downregulated at week 24 in the 10 lung tumor tissues of individual mice treated with urethane. Thus, the sequencing results were confirmed by qRT-PCR. We observed no significant changes in miR-193 in the 10 paired lung tumor tissues of the urethane-treated group at week 24 (data not shown). The copy numbers of the miRNA transcripts revealed by Solexa sequencing reflect their abundance in the tissues. Our sequencing results revealed that there were abundant copies of miR-1a in the normal adjacent lung tissues and lung tumors of the urethane-treated group. Moreover, there were marked changes in miRNA expression between the lung tumors and the normal adjacent lung tissues in the urethane-injected mice, which were up to 16-fold for miR-1a (Table 1) . Therefore, we selected miR-1a for further study.
Dynamic Changes in miR-1a in the Lung Tissues of Mice Exposed to Urethane
We investigated whether the changes in miR-1a were associated with pulmonary carcinogenesis induced by urethane. The changes in miR-1a expression at three different time points were determined. First, miR-1a was evaluated in the lung tissues of saline-injected and urethane-injected mice before the appearance of tumors in the latter mice. We detected the expression of miR-1a by qRT-PCR in the lung tissues at week 6. Compared with the normal lung tissues of the salineinjected group, miR-1a expression was significantly reduced in the lung tissues of the urethane-treated group (Fig. 5A and Supplementary table S5). qRT-PCR was performed to investigate the expression of miR-1a in the normal lung tissues of the saline-injected mice and in the lung tumor tissues and paired normal lung tissues of the urethane-injected mice after the appearance of tumors in the latter group at week 12. As shown in Figure 5B , compared with the normal lung tissues of the saline-injected mice, the expression of miR-1a was significantly reduced in the normal lung tissues of the tumorbearing mice (n = 9) among the urethane-treated mice and in the lung tumor tissues of the urethane-injected mice (n = 9). miR-1a expression levels were also significantly downregulated in the lung tumor tissues relative to those in the matched normal lung tissues of the urethane-injected mice. At week 24, significantly downregulated miR-1a levels were also observed in the lung tumors (n = 10) compared with those in the matched normal lung tissues of the urethane-injected mice (Fig. 5C ). qRT-PCR also revealed a reduction in miR-1a in the matched normal lung tissues of the urethane-injected mice (n = 10) compared with that in the lung tissues of the saline-injected mice (n = 10), but these changes were not significant. We also quantified miR-1a expression in the kidney and heart tissues at week 24, but no significant difference was observed between the control and urethane-treated groups (Supplementary fig. S2 ). 
Levels of miR-1a Expression Were Altered in Mouse Serum Samples
In response to a previous report (Ng et al., 2009) and as recommended by the manufacturer (Applied Biosystems), we evaluated the variability in the miR-16 CT values in the mouse sera before quantifying the miR-1a expression in the sera. Our results suggested that the CT values for miR-16 in mouse serum did not differ significantly between the control and urethanetreated groups (Supplementary fig. S1B ). Therefore, miR-16 was used as the reference gene for data normalization for the serum samples. Tissue or organ miRNA is potentially released into the circulation upon exposure to external stimuli or under certain disease conditions (Sukata et al., 2011) . Therefore, we analyzed the potential impact of tumorigenesis on serum miR1a levels at different stages of lung carcinogenesis induced by urethane. The miR-1a expression level in the serum of each animal (n = 10 for both the saline-and urethane-treated groups at weeks 6 and 24; n = 10 for the saline-treated group and n = 9 for the urethane-treated group at week 12) was evaluated at 6, 12, and 24 weeks after urethane induction. As shown in Figure 6 , serum miR-1a was significantly reduced in the urethane-treated mouse sera at week 6; this reduction in miR-1a was maintained in the sera of the tumor-bearing mice at weeks 12 and 24 compared with that in the saline-treated mouse sera. These results indicate that the downregulation of miR-1a expression in the lung tissues (compared with that in saline-treated mice) paralleled its reduction in the sera of mice treated with urethane during urethane-induced pulmonary carcinogenesis.
dISCUSSION
Chemical carcinogens induce multiple molecular events in lung cancer. Recently, several studies have reported that changes in miRNA expression are associated with chemical carcinogenesis (Wang et al., 2011; Zhang and Pan, 2009 ). Identification of these molecular changes could provide profound insight into the tumorigenesis induced by chemicals. To further clarify the association between miRNA and lung carcinogenesis, we constructed a mouse model using the carcinogen urethane. To examine miRNA profiles in pulmonary carcinogenesis during tumorigenesis, a longitudinal analysis of miR-1a was performed in the lung tissues and sera of these mice. In this study, we identified a large set of miRNAs that are differentially expressed in the lung tumor tissues of mice treated with urethane.
Among these differentially expressed miRNAs, miR-1a was selected for further analysis because abundant copies of it were found with deep sequencing and there were marked changes in its expression. There was a significant loss of miR1a in the lung tissues of mice treated with urethane, which developed lung carcinogenesis, at the three time points examined. Several reports have suggested that the downregulation of miR-1a occurs in a variety of human cancers, including , where ΔCT was calculated by subtracting the CT value for U6 snRNA from the CT value for each miRNA detected in the corresponding sample. The horizontal line in each box (B, D, F, and H) represents the median value for the miRNA normalized to U6 snRNA in each group. The box denotes the 5th to 95th percentile range of scores, and the whiskers represent the highest and lowest values. Paired Student's t-test was used to ascertain the statistical significance of the differences between the expression levels in the paired normal lung tissues and lung tumors in the urethane-injected mice. A double asterisk indicates a significant difference from the control (**p < 0.01).
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miRNA PRofiles ANd miR-1A iN CARCiNogeNesis prostate cancer (Hudson et al., 2012) , rhabdomyosarcoma (Yan et al., 2009) , and lung cancer (Nasser et al., 2008) . In our study, we observed the downregulation of miR-1a in lung tumors compared with its expression in normal adjacent lung tissue after exposure to urethane and relative to its expression in the lung tissues of mice not treated with urethane. Moreover, the levels of miR-1a expression in other organs, such as the kidney and heart, did not differ significantly between the urethane-treated and untreated groups. More importantly, our findings indicate that the reduction in miR-1a in the lung tissues occurred before tumorigenesis, in week 6, and that this effect was enhanced when normal mouse lung tissues were transformed into malignant tissues after exposure to urethane. Because the changes in miR-1a may have occurred before lung tumor formation, the downregulation of miR-1a was not a consequence of the malignant transformation induced by urethane. These results should give insight into the molecular changes induced by urethane in the early stages of pulmonary carcinogenesis. They may also provide a clue to a potential marker of pulmonary tumorigenesis. To fully clarify the role of miR-1a downregulation in the biological response to urethane, further investigation of the dose-dependent response to urethane and the reason for this reduction in miR-1a is necessary.
As we know, miRNAs can interact with a variety of target genes to exert their functions. Human miR-1, of which mature sequence is the same as mouse mature miR-1a sequence, modulates multiple cancer processes by influencing oncogenic TAGLN2 in renal cell carcinoma (Kawakami et al., 2012) . Tominaga et al. (2013) reported that miR-1 potentially targets certain sites on the Slug 3′-UTR to influence lung cancer malignancy. miR-1 can target CCND2 and CXCR4 and is involved in thyroid cell proliferation and migration (Leone et al., 2011) . These studies have shown that human miR-1 is involved as a suppressor gene in tumorigenesis in human cancers. The balance between cell proliferation and apoptosis is often disrupted and contributes to tumorigenesis in many types of cancer (Cotter, 2009) . Previous research in vitro has demonstrated that the reintroduction of miR-1 into lung cancer cells impairs cell proliferation and induces apoptosis (Nasser et al., 2008) . It is likely that the restoration of this miRNA to the neoplastic lung affects tumor progression. Because mouse miR-1a and human miR-1 share the same mature seqence, miR-1a may have the similar targets found in human cancer. Taking into account the established role of miR-1 in human cancers and the persistent downregulation of miR-1a expression during pulmonary tumorigenesis, we speculate that the reduction in miR-1a upregulates the expression of many genes that control cell proliferation and cell death. In the case of chronic urethane exposure, this is likely to contribute to lung tumor formation in vivo. In the next phase of our research, we will address the mechanism underlying the activity of miR-1a in urethane-induced pulmonary carcinogenesis and further evaluate the targets of miR-1a during this process.
FIg. 5.
Expression changes in miR-1a during lung carcinogenesis induced by urethane. Quantitative representations of data using box plots at week 6 (A), week 12 (B), and week 24 (C). C, Normal lung tissue in the saline-injected control group; N, normal adjacent lung tissue in the urethane-injected group; T, lung tumor tissue in the urethane-injected group; U6 snRNA was used as the reference gene. Using qRT-PCR, the expression level of miR-1a is presented as 2 −ΔCT at each time point. The horizontal line in each box represents the median value. ANOVA was used to determine statistical significance. A single asterisk indicates a significant difference from the control (*p < 0.05); a double asterisk indicates a more significant difference from the control (**p < 0.01).
FIg. 6. Downregulation of miR-1a in the sera of mice exposed to urethane. Box plots comparing miR-1a levels in the mouse sera of the salinetreated control group and the urethane-treated group at weeks 6, 12, and 24. C represents the saline-treated control group; T represents the urethane-treated group. Relative miR-1a expression was determined with qRT-PCR after normalization to miR-16. Each sample was analyzed in triplicate. The lines inside the boxes denote the median values. The Mann-Whitney test was used to determine statistical significance. A double asterisk indicates a significant difference from the control (**p < 0.01).
We also analyzed the levels of serum miR-1a expression in individual mice during pulmonary carcinogenesis induced with urethane. Our results show that the levels of miR-1a in mouse sera decreased before tumor formation at 6 weeks; this reduction of serum miR-1a was sustained at weeks 12 and 24, correlating with tumor appearance. It has recently been shown that the same pattern of miRNAs is observed in the tissues and sera of patients with pancreatic cancer (LaConti et al., 2011) and prostate cancer (Selth et al., 2012) . The mechanisms underlying the release of miRNA into the circulation remain unclear. One possible mechanism is that miRNAs derived from tissues are released into the bloodstream in a continuous manner, probably via exosomes (Valadi et al., 2007) . In our study, we hypothesized that the expression of miR-1a in the lung tissues was reduced, so the amount released into the circulation decreased. However, we cannot exclude the possibility of other release mechanisms. Our results suggest that abnormal levels of miR-1a in the circulation are a potential marker of lung cancer induced by chemical carcinogens.
In conclusion, using deep sequencing, we determined the expression profiles of differentially expressed miRNAs. These aberrantly expressed miRNAs may play roles in the lung carcinogenesis induced by urethane. Importantly, the underexpression of miR-1a in the lung tissues and serum indicated that miR-1a is associated with urethane-induced pulmonary carcinogenesis.
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